News Korro Bio, Inc.

Equities

KRRO

US5009461089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
54.88 ^USD	+4.89%		-5.74%	+14.50%

Apr. 24	Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	MT
Apr. 24	Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio, Inc. announced that it has received $69.959848 million in funding from Atlas Venture L.P., Deep Track Capital, LP, Blue Owl Healthcare Opportunities, Rock Springs Capital Management LP, Tri Locum Partners LP, New Enterprise Associates, Inc.	Apr. 21	CI
Korro Announces $70 Million Private Placement	Apr. 18	AQ
Korro Bio, Inc. announced that it expects to receive $69.959848 million in funding from Atlas Venture L.P.	Apr. 16	CI
Korro to Participate in Upcoming Investor Conferences	Apr. 01	AQ
HC Wainwright Adjusts Korro Bio's Price Target to $115 From $100, Buy Rating Kept	Mar. 28	MT
RBC Boosts Price Target on Korro Bio to $90 From $70 on 'Increased Conviction for A1AT,' Keeps Outperform, Speculative Risk	Mar. 27	MT
Korro Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress	Mar. 26	AQ
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
North American Morning Briefing : Inflation -2-	Mar. 15	DJ
Korro Bio: Development and Application of Graph Neural Networks to Design Guide Oligonucleotides that Promote RNA Editing	Mar. 13	PU
BMO Capital Initiates Korro Bio With Outperform Rating, Price Target is $120	Feb. 27	MT
Korro to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Korro Bio, Inc.

Equities

KRRO

US5009461089

Summary

Filters